Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic and pharmacodynamic study evaluating intravenous linezolid in MRSA-positive, morbidly obese patients with pneumonia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Linezolid (Linezolid)

Snippet

Sponsor: University Ghent | Conditions: Pneumonia | Phase 4 | Status: COMPLETED